Retreatment of IFN/ribavirin non-responder hepatitis C patients: Benefit of PEG-interferon/ribavirin amantadine.

被引：0
|
作者：
Maynard, M
Ahmed, SNS
Bailly, F
Rozier, F
Benmakhlouf, N
Bourne-Branchu, V
Fazly, T
Nemoz, C
Adeleine, P
Pradat, P
Trepo, C
机构：
[1] Hop Hotel Dieu, Lyon, France
[2] Hosp Civils Lyon, Lyon, France
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：398A / 398A
页数：1
相关论文
共 50 条
  • [41] Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C
    Taliani, G
    Biliotti, E
    Capanni, M
    Tozzi, A
    Bresci, S
    Pimpinelli, N
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (02) : 212 - 214
  • [42] Extended Treatment with Peg-Interferon and Ribavirin for Recurrent Hepatitis C after Liver Transplantation
    Tufail, Kashif
    Hashemi, Nikroo
    Azhar, Ashaur
    Feyssa, Eyob
    Niazi, Mumtaz
    Ortiz, Jorge
    Araya, Victor
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S94 - S94
  • [43] Treatment with PEG-interferon and Ribavirin for Chronic Hepatitis C Increases Neutrophil and Monocyte Chemotaxis
    Giorgini, Alessia
    Capsoni, Franco
    Podda, Mauro
    Lleo, Ana
    Battezzati, Pier Maria
    Ongari, Anna Maria
    Selmi, Carlo
    Benetti, Alberto
    Malinverno, Federica
    Rossaro, Lorenzo
    Gershwin, M. Eric
    Zuin, Massimo
    CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 : 847 - 857
  • [44] Acquired endocrine disorders after peg-interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Wang, T-E
    Chen, M-J
    Liou, T-C
    Wang, H-Y
    Chu, C-H
    Chen, C-J
    Hu, K-C
    Shih, S-C
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A181 - A182
  • [45] Retreatment of chronic hepatitis C patients with interferon plus ribavirin vs interferon alone
    Vandelli, C
    Renzo, F
    Vecchi, C
    Lovato, E
    Tisminetzky, S
    Ventura, E
    JOURNAL OF HEPATOLOGY, 2000, 32 : 191 - 191
  • [46] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Goncales, Fernando L., Jr.
    Moma, Camila A.
    Vigani, Aline G.
    Angerami, Adriana F. C. F.
    Goncales, Eduardo S. L.
    Tozzo, Raquel
    Pavan, Maria H. P.
    Goncales, Neiva S. L.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [47] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Fernando L Gonçales
    Camila A Moma
    Aline G Vigani
    Adriana FCF Angerami
    Eduardo SL Gonçales
    Raquel Tozzo
    Maria HP Pavan
    Neiva SL Gonçales
    BMC Infectious Diseases, 10
  • [48] Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C
    Puig-Basagoiti, F
    Forns, X
    Furcic, I
    Ampurdanés, S
    Giménez-Barcons, M
    Franco, S
    Sanchez-Tapias, JM
    Saiz, JC
    JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 1067 - 1075
  • [49] Treatment with PEG-interferon and ribavirin for chronic hepatitis C does not decrease neutrophil and monocyte activity
    Giorgini, A.
    Capsoni, F.
    Lleo, A.
    Selmi, C.
    Ongari, A. M.
    Benetti, A.
    Ferrari, B.
    Invernizzi, P.
    Podda, M.
    Zuin, M.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S198 - S198
  • [50] Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients
    Pawelczyk, A.
    Pawelczyk, T.
    Rabe-Jablonska, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S74 - S75
12345